Anbio Biotechnology (NNNN) is in Healthcare, Medical Instruments & Supplies, based in Germany, listed on NasdaqGM. Market cap 202.78M USD. 52-week range 4.55 to 44.73 USD. Trailing P/E 30.8. Data as of 2026-10-09.
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and ...